Phase II Clinical Trial With the Combination Gemcitabine, Oxaliplatin and Vinorelbine as First Line Treatment in Patients With Non-Small Cell Bronchopulmonary Cancer.
Phase of Trial: Phase II
Latest Information Update: 03 Feb 2010
At a glance
- Drugs Gemcitabine; Oxaliplatin; Vinorelbine
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms GON
- Sponsors Sanofi
- 27 Aug 2007 Status change from in progress to completed.
- 12 Sep 2006 New trial record.